Bioyitech Awarded the 2024 Shanghai Specialized and Innovative Honor

Recently, Bioyitech distinguished itself among numerous enterprises by receiving the "Specialized and Innovative Small and Medium-sized Enterprises" honor awarded by the Shanghai Municipal Commission of Economy and Informatization. This recognition is a testament to Bioyitech's achievements in technological innovation, market performance, and corporate management.

According to the "Implementation Guidelines for the Gradual Cultivation and Management of Quality Small and Medium-sized Enterprises in Shanghai," Bioyitech has been identified as one of the specialized and innovative small and medium-sized enterprises for 2024 following expert reviews and comprehensive evaluations. This accolade not only showcases Bioyitech's strength and influence within the industry but also reflects the company's ongoing efforts and exploration in the specialized and innovative sector.

The recognition by the Shanghai Municipal Commission of Economy and Informatization aims to promote the high-quality development of small and medium-sized enterprises, enhancing their innovation capabilities, market competitiveness, and sense of social responsibility. Enterprises awarded this recognition must be registered in Shanghai, possess independent legal status, meet the classification standards for small and medium-sized enterprises, and have no significant safety, quality, or environmental pollution incidents in the past three years.

Bioyitech stated that receiving the title of Specialized and Innovative Small and Medium-sized Enterprise is an acknowledgment of the company's past efforts and a motivation for future development. The company will continue to adhere to innovation-driven strategies, improve product quality, provide superior services to customers, and contribute significantly to the industry's advancement.

Regarding Bioyitech:

Bioyitech has consistently adhered to scientific research and continuous innovation, establishing strategic collaborations with institutions such as Northeast Agricultural University, Harbin Institute of Technology, Ocean University of China, Zhejiang Chinese Medical University, Dalian University of Technology, and Shenyang Normal University, among others. The company has isolated, identified, and preserved over 6,000 strains of lactic acid bacteria from naturally fermented foods across the country, as well as from healthy populations' intestines and breast milk, developing 102 unique functional strains, thereby making significant contributions to the cultivation of indigenous bacteria in China.

Bioyitech believes that the domestication of microorganisms represents an invisible form of "agriculture." It serves as a microscopic key linking to overall health, and this "micro" industry, which is not visible, must achieve national self-reliance and strength. As of 2022, Bioyitech has applied for 14 patents related to strains, published over 120 scientific papers, and participated in more than 20 international and provincial-level research projects, earning the title of a specialized and innovative enterprise in Shanghai. In the future, Bioyitech aims to collaborate with major research institutions in the field of scientific research to further promote the integration of production, education, and research, providing the public with safer, more efficient, and market-promising probiotic products.